Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aeterna Zentaris licenses anticancer agent to Hikma

Nov. 24, 2011

Amgen tests antibody-drug conjugate targeting EGFRvIII

Nov. 24, 2011

Updated results presented from ongoing first-in-patient trial of PF-04691502

Nov. 24, 2011

Celgene to discontinue study of treatment regimen for castration-resistant prostate cancer

Nov. 23, 2011

EMA committee recommends approval of new indication for Herceptin

Nov. 23, 2011

Swissmedic approves Celgene's Revlimid

Nov. 23, 2011

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

Bendamustine evaluated in anaplastic glioma

Nov. 23, 2011

Cabozantinib trial begins in hormone receptor-positive breast cancer

Nov. 22, 2011

Merrimack Pharmaceuticals begins enrollment in MM-121/erlotinib combination trial

Nov. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026